VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
LFMDLifeMD, Inc.
$4.31$208M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksLFMDP/E History

LFMD logoLifeMD, Inc. (LFMD) P/E Ratio History

Deep Value

Trading at -18.7x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2018–2018

Current P/E (TTM)
-18.7x
-180% vs 5Y avg
5Y Avg P/E
23.3x
Median 23.3x
5Y Percentile
0th
Lower end of range
PEG Ratio
N/A
TTM EPS$-0.36
Price$4.31
Earnings YieldN/A
EPS Growth (1Y)56.6%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of June 23, 2026, LifeMD, Inc. (LFMD) trades at a price-to-earnings ratio of -18.7x, with a stock price of $4.31 and trailing twelve-month earnings per share of $-0.36.

The current P/E is 180% below its 5-year average of 23.3x. Over the past five years, LFMD's P/E has ranged from a low of 23.3x to a high of 23.3x, placing the current valuation at the 0th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.1x, LFMD trades at a 185% discount to its sector peers. The sector includes 233 companies with P/E ratios ranging from 0.0x to 194.5x.

Relative to the broader market, LFMD trades at a notable discount to the S&P 500 median P/E of 24.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our LFMD DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

LFMD Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
-18.7vs22.1
-185%
Below Sector
vs. S&P 500
-18.7vs24.3
-177%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 57% EPS growth (1Y)

LFMD P/E vs Peers

Digital Health and Online Pharmacy peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
HIMS logoHIMSHims & Hers Health, Inc.
$7B65.8--4%
DOCS logoDOCSDoximity, Inc.
$4B20.50.40Best-12%
OPRX logoOPRXOptimizeRx Corporation
$88M17.3Lowest-+125%Best
TALK logoTALKTalkspace, Inc.
$873M130.3--
GDRX logoGDRXGoodRx Holdings, Inc.
$891M30.1-+104%
CVS logoCVSCVS Health Corporation
$129B72.9--62%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

LFMD Historical P/E Data (2018–2018)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2018 Q1Mar 31 2018$1.40$0.0623.3x+0%

Average P/E for displayed period: 23.3x

Export Data
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

8+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

LFMD — Frequently Asked Questions

Quick answers to the most common questions about buying LFMD stock.

What is LFMD's P/E ratio?

LifeMD, Inc. (LFMD) trailing twelve-month P/E ratio is -18.7x, based on TTM diluted EPS of $-0.36. The 5-year average P/E is 23.3x and the historical range spans 23.3x to 23.3x.

Is LFMD stock overvalued or undervalued?

LFMD trades at -18.7x P/E, below its 5-year average of 23.3x. At the 0th percentile of its historical range (23.3x–23.3x), the stock is priced at a discount to its own history.

Is LFMD stock expensive?

No, LFMD is not expensive on a historical basis. The current P/E of -18.7x is below the 5-year average of 23.3x and sits at the 0th percentile of its valuation range.

What is LFMD's historical P/E range?

Over the past 5 years, LFMD's P/E ratio has ranged from 23.3x to 23.3x, with a median of 23.3x and an average of 23.3x. The current P/E of -18.7x places the stock at the 0th percentile of this range. Full historical data spans 2018–2018.

How does LFMD's P/E compare to the S&P 500?

LFMD trades at -18.7x P/E versus the S&P 500 median of 24.3x. The 177% discount to the market suggests lower growth expectations or perceived higher risk.

How does LFMD's valuation compare to Healthcare peers?

LifeMD, Inc. P/E of -18.7x compares to the Healthcare sector median of 22.1x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is LFMD's PEG ratio?

LFMD PEG ratio is N/A, based on a P/E of -18.7x and EPS growth of 56.6%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is LFMD's earnings yield?

LFMD earnings yield is N/A, the inverse of its -18.7x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

LFMD P/E Ratio History (2018–2018)

Quarterly valuation multiple from closing price and trailing EPS

Current23.3x
Period Avg23.3x
Range23.3x - 23.3x
Change+0%
1 quartersMar 31, 2018 - Mar 31, 2018